San Francisco Bay Area biotech stories.
Friday, July 15, 2011
Genentech: Breast cancer drug hits its mark in late-stage trial
A late-stage breast cancer trial showed that a Roche Group drug, combined with the popular cancer fighter Herceptin and chemotherapy, hit its main goal in women with a form of breast cancer that has spread to other parts of the body.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)